Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Baxter
Accenture
Fish and Richardson
AstraZeneca
Julphar
McKinsey
Cipla

Generated: December 12, 2018

DrugPatentWatch Database Preview

KETOTIFEN FUMARATE Drug Profile

« Back to Dashboard

When do Ketotifen Fumarate patents expire, and what generic alternatives are available?

Ketotifen Fumarate is a drug marketed by Akorn, Alcon Pharms Ltd, and Apotex Inc. and is included in three NDAs.

The generic ingredient in KETOTIFEN FUMARATE is ketotifen fumarate. There are five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ketotifen fumarate profile page.

Drug patent expirations by year for KETOTIFEN FUMARATE
Medical Subject Heading (MeSH) Categories for KETOTIFEN FUMARATE
Synonyms for KETOTIFEN FUMARATE
(2E)-BUT-2-ENEDIOIC ACID; 2-(1-METHYLPIPERIDIN-4-YLIDENE)-6-THIATRICYCLO[8.4.0.0(3),?]TETRADECA-1(10),3(7),4,11,13-PENTAEN-8-ONE
(E)-but-2-enedioic acid;10-(1-methylpiperidin-4-ylidene)-5H-benzo[1,2]cyclohepta[2,4-b]thiophen-4-one
10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (E)-2-butenedioate (1:1)
126939-14-8
34580-14-8
4-(1-Methyl-4-piperidylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one hydrogen fumarate
4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one fumarate
4,9-Dihydro-4-(1-methyl-4-piperidinylidene-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one fumarate
4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one fumarate (1:1)
4,9-Dihydro-4-(1-methylpiperidin-4-ylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophene-10-one fumarate
580K148
AB0013347
AB1009287
AC-7589
AK139144
AKOS008901371
Alaway
AN-674
BCP0726000236
BCP9000812
butenedioic acid; ketotifen
C19H21NOS.C4H4O4
C23H23NO5S
CCG-101110
CCG-40319
CHEBI:31750
CHEMBL1633
CPD000058462
CS-1988
D01332
EINECS 252-100-0
EU-0100706
FT-0082715
fumaric acid; ketotifen
H904
HBD503WORO
HC 20,511 fumarate
HC-20511
HC-20511 fumarate
HMS1569K03
HMS1921A12
HMS2052O11
HMS2092G16
HMS2096K03
HMS2232K10
HMS2233C06
HMS3262M13
HMS3266D20
HMS500F13
HY-B0157A
J-019659
K 2628
K0048
KB-53037
Ketotifen (fumarate)
Ketotifen for peak identification, European Pharmacopoeia (EP) Reference Standard
Ketotifen fumarate (JP17/USAN)
Ketotifen fumarate (Zaditor)
Ketotifen fumarate [USAN:JAN]
Ketotifen fumarate salt
Ketotifen fumerate
Ketotifen hydrogen fumarate
Ketotifen Hydrogen Fumarate 1.0 mg/ml in Methanol (as free base)
Ketotifen hydrogen fumarate, European Pharmacopoeia (EP) Reference Standard
KS-1206
LP00706
LS-33821
MFCD00079394
MLS000069701
MLS000758236
MLS001148200
MLS001401421
MolPort-003-666-315
NC00360
NCGC00094057-01
NCGC00094057-02
NCGC00094057-03
NCGC00094057-04
NCGC00094057-05
NCGC00261391-01
NSC-757415
NSC757415
Opera_ID_1952
Pharmakon1600-01500668
PL008605
Prestwick_743
REGID_for_CID_5282408
s2024
SAM001246984
SCHEMBL8809
SCHEMBL8810
SMR000058462
SMR000653460
SPECTRUM1500668
SR-01000075951
SR-01000075951-1
ST51053512
Tox21_500706
UNII-HBD503WORO
YNQQEYBLVYAWNX-WLHGVMLRSA-N
Zaditen
Zaditen (TN)

US Patents and Regulatory Information for KETOTIFEN FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn KETOTIFEN FUMARATE ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 077958-001 Jul 26, 2007 OTC No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alcon Pharms Ltd KETOTIFEN FUMARATE ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 077200-001 Sep 2, 2008 OTC No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc KETOTIFEN FUMARATE ketotifen fumarate SOLUTION/DROPS;OPHTHALMIC 077354-001 May 9, 2006 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Daiichi Sankyo
Julphar
Chubb
Fish and Richardson
Queensland Health
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.